SNY
Sanofi ADR
Sanofi ADR historical holders
total: 11
Causeway Capital Management Sanofi ADR transactions over time
- Total transactions:
- 44
- New positions:
- 2
- Sold out:
- 1
- Added:
- 25
- Reduced:
- 16
- Held since:
- 2020 Q2
- Held for:
- 24 quarters
- Latest activity:
- 2026 Q1
Sarah Ketterer has been an institutional investor in Sanofi ADR (SNY) since at least 2013 Q2. According to 2026 Q1 report, Sarah Ketterer holds 1,064,516 shares with a market value of roughly $51.29M representing 0.63% of their equity portfolio. In our earliest available record from 2013 Q2, Causeway Capital Management held 88,394 shares of SNY. Sarah Ketterer later completely sold out the position and reinvested in SNY again in 2020 Q2. Since at least 2013 Q2, Causeway Capital Management has made 43 more transactions in this position.
Does Sarah Ketterer still hold SNY?
Yes, Sarah Ketterer continues to hold Sanofi ADR (SNY). According to their 2026 Q1 report, they maintain a position of 1,064,516 shares valued at approximately $51.29M, representing 0.63% of their equity portfolio.
Has Sarah Ketterer reinvested in SNY after selling?
Yes, Sarah Ketterer has shown renewed interest in Sanofi ADR (SNY). After completely selling their position, they reinitiated an investment in 2020 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $49.69
- Weighted AVG sell price:
- $49.30
SNY transactions history by Causeway Capital Management
44 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.63%
|
1,064,516
|
$48.18
|
$51,288,367
|
+0.05% (+558)
|
+0%
|
|
2025 Q4
|
0.71%
|
1,063,958
|
$48.46
|
$51,559,385
|
+8.64% (+84,641)
|
+0.06%
|
|
2025 Q3
|
0.61%
|
979,317
|
$47.20
|
$46,223,771
|
+16.64% (+139,678)
|
+0.09%
|
|
2025 Q2
|
0.64%
|
839,639
|
$48.31
|
$40,562,944
|
+21.11% (+146,378)
|
+0.11%
|
|
2025 Q1
|
0.80%
|
693,261
|
$55.46
|
$38,448,233
|
+0.41% (+2,825)
|
+0%
|
|
2024 Q4
|
0.76%
|
690,436
|
$48.23
|
$33,299,707
|
+38.79% (+192,954)
|
+0.21%
|
|
2024 Q3
|
0.70%
|
497,482
|
$57.63
|
$28,669,890
|
+3.33% (+16,017)
|
+0.02%
|
|
2024 Q2
|
0.64%
|
481,465
|
$48.52
|
$23,360,685
|
+3.35% (+15,586)
|
+0.02%
|
|
2024 Q1
|
0.59%
|
465,879
|
$48.60
|
$22,641,717
|
+5.34% (+23,610)
|
+0.03%
|
|
2023 Q4
|
0.56%
|
442,269
|
$49.73
|
$21,994,047
|
-7.98% (-38,373)
|
-0.05%
|
|
2023 Q3
|
0.68%
|
$53.64
|
+29.18% (+108,574)
|
|||
|
2023 Q2
|
0.53%
|
$53.90
|
+8.66% (+29,650)
|
|||
|
2023 Q1
|
0.45%
|
$54.42
|
-15.34% (-62,039)
|
|||
|
2022 Q4
|
0.57%
|
$48.43
|
-12.85% (-59,610)
|
|||
|
2022 Q3
|
0.49%
|
$38.02
|
-6.57% (-32,614)
|
|||
|
2022 Q2
|
0.62%
|
$50.03
|
-18.60% (-113,502)
|
|||
|
2022 Q1
|
0.75%
|
$51.34
|
-4.56% (-29,122)
|
|||
|
2021 Q4
|
0.70%
|
$50.10
|
+0.52% (+3,289)
|
|||
|
2021 Q3
|
0.69%
|
$48.21
|
-7.39% (-50,781)
|
|||
|
2021 Q2
|
0.74%
|
$52.66
|
+8.16% (+51,841)
|
|||
|
2021 Q1
|
0.62%
|
$49.46
|
+41.23% (+185,370)
|
|||
|
2020 Q4
|
0.41%
|
$48.59
|
+38.46% (+124,878)
|
|||
|
2020 Q3
|
0.30%
|
$50.17
|
+86.31% (+150,423)
|
|||
|
2020 Q2
|
0.16%
|
$51.05
|
new
|
|||
|
2018 Q1
|
0.00%
|
$44.32
|
-100% (-361)
|
|||
|
2017 Q4
|
0.00%
|
$44.32
|
-37.22% (-214)
|
|||
|
2017 Q3
|
0.00%
|
$50.43
|
-99.41% (-96,461)
|
|||
|
2017 Q2
|
0.06%
|
$47.91
|
-68.25% (-208,584)
|
|||
|
2017 Q1
|
0.19%
|
$45.25
|
-13.38% (-47,221)
|
|||
|
2016 Q4
|
0.24%
|
$39.36
|
-10.56% (-41,666)
|
|||
|
2016 Q3
|
0.28%
|
$38.19
|
+0.18% (+726)
|
|||
|
2016 Q2
|
0.35%
|
$41.85
|
+0.55% (+2,168)
|
|||
|
2016 Q1
|
0.37%
|
$41.10
|
-8.70% (-37,310)
|
|||
|
2015 Q4
|
0.39%
|
$42.65
|
-25.38% (-145,860)
|
|||
|
2015 Q3
|
0.55%
|
$47.47
|
+11.37% (+58,668)
|
|||
|
2015 Q2
|
0.64%
|
$49.53
|
+8.12% (+38,748)
|
|||
|
2015 Q1
|
0.62%
|
$49.44
|
-5.81% (-29,429)
|
|||
|
2014 Q4
|
0.67%
|
$45.61
|
-14.67% (-87,133)
|
|||
|
2014 Q3
|
1.16%
|
$56.43
|
+4.58% (+26,008)
|
|||
|
2014 Q2
|
1.21%
|
$52.27
|
+12.04% (+61,020)
|
|||
|
2014 Q1
|
1.19%
|
$52.28
|
+17.52% (+75,584)
|
|||
|
2013 Q4
|
1.31%
|
$53.63
|
+277.96% (+317,199)
|
|||
|
2013 Q3
|
0.47%
|
$50.63
|
+29.10% (+25,724)
|
|||
|
2013 Q2
|
0.48%
|
$51.51
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.